A shingles shot might do more than prevent a painful rash — it could actually help slow down the aging process. In a large national study of more than 3,800 Americans age 70 and older, those who received the shingles vaccine showed slower biological aging compared to those who didn’t. Researchers found lower levels of chronic inflammation and slower changes in gene activity linked to aging, sugges
A sweeping new analysis of the evidence suggests that exercise therapy — long promoted as a first-line treatment for osteoarthritis — may offer only small and short-lived relief, and in some cases might be no better than doing nothing at all. After reviewing dozens of clinical trials involving more than 13,000 participants, researchers found that benefits for knee osteoarthritis pain were minimal
Casey Means wanted to talk about chronic disease. But Bill Cassidy wanted to hear about her views on vaccines.
Drugmakers thought they had the FDA's buy-in to approve a therapy to treat a type of cancer that can quickly turn deadly. The agency, however, rejected it.
GSK's every-two-month injection kept adolescents with HIV virologically suppressed at 96 weeks, GSK's ViiV presented at the recent Conference on Retroviruses and Opportunistic Infections.
A top federal health official said he hopes the Trump administration’s efforts to whittle down the insurance industry’s use of prior authorizations will produce results “in double-digit months” instead of…
The treatment landscape for clear cell renal cell carcinoma could be due for a shake-up following dual breakthroughs from Merck’s Litespark clinical trial program for Welireg. But one critical factor could hinder these Welireg regimens from shifting from potential treatment options to the universal standard of care.
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is offloading its entire contract manufacturing operation and some of its European discovery service assets, which brought in a combined $287 million in revenue last year.
In developing media plans to reach the GLP-1-interested consumer, audio advertising may represent a “blind spot,” according to Anna Clement, director head of industry for SiriusXM Media’s pharma vertical.
When BridgeBio presented its quarterly report on Tuesday, it laid out expectations on the potential threat of generic pricing pressure on Attruby and provided more evidence of the drug's strong launch, possibly giving investors a dose of reassurance.
Eating nothing but oatmeal for just two days might sound extreme, but it delivered a striking payoff in a new clinical trial. People with metabolic syndrome who followed a short, calorie-reduced oat-based plan saw their harmful LDL cholesterol drop by 10%, along with modest weight loss and lower blood pressure. Even more surprising, the cholesterol benefits were still visible six weeks later.
Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as “Brain on Fire.” The disease strikes when the immune system attacks NMDA receptors—key molecules involved in memory and thinking—leading to psychiatric symptoms, seizures, and even death.
Sanofi has kicked off its preparations for the 2026 World Cup by becoming an official backer of Boston’s involvement in the soccer showcase.
“We're just setting up a generation of people to move through life, having their cardiovascular events earlier and more severe."
Dentistry has long been built on preventive care. It’s time to extend that preventive mindset to substance use.
Maintaining the capacity to provide care close to home for rural patients is critical, but it’s under threat.
A gel-like sugar coating on immune cells has been found to play a starring role in psoriasis. Researchers discovered that immune cells shed this outer layer to help them exit the bloodstream and enter inflamed skin. This challenges the long-held idea that only blood vessel walls changed during this process. The finding could help guide new therapies aimed at controlling harmful inflammation.
A weeklong, high-intensity version of TMS may work nearly as well as the standard six-week treatment for depression. In a UCLA study, patients who received five sessions a day for five days experienced meaningful symptom relief comparable to those on the traditional schedule. Some who didn’t improve immediately showed strong gains weeks later. The findings hint at a faster, more accessible path to
Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue. Scientists say this is the first Western study to directly measure plastic particles in prostate tumors. More research is needed, but the findings suggest microplastic exposure could play a role in cancer deve
The company unveiled detailed results from its pair of late-stage Artistry trials this week at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.